Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression
Crossref DOI link: https://doi.org/10.1007/s00262-017-2059-y
Published Online: 2017-09-13
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hebb, Jonathan P. O.
Mosley, Adriane R.
Vences-Catalán, Felipe
Rajasekaran, Narendiran
Rosén, Anna
Ellmark, Peter
Felsher, Dean W.
Funding for this research was provided by:
Alligator Bioscience
License valid from 2017-09-13